…
MEDIROM Healthcare Technologies Inc., together with its subsidiaries, provides holistic health services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment develops, owns, operates, franchises, and supports relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. This segment operates relaxation salons under the Re.Ra.Ku and Ruam Ruam brands. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program that utilizes Lav, an on-demand health monitoring smartphone application, as well as MOTHER Bracelet for fitness and health applications; and provides preventative healthcare services utilizing nutritionists and health nurses. The Luxury Beauty segment manages and operates hair salons under the ZACC brand name. The company also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on Medirom Healthcare Technologies Inc. (NASDAQ: MRM) is limited; company disclosures identify it as operating in the healthcare technology sector. It may benefit from secular trends such as digitization of medical workflows and demand for cost-efficient clinical solutions, which could support long-term revenue growth and make it of interest to investors seeking exposure to small-cap digital health names.
Material risks include limited public disclosure and transparency, small-cap liquidity and execution risk, possible financial and regulatory uncertainty, and substantial competitive pressure in healthcare technology.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 0.38M | 47.71M | 20.62M | -414.48M | -414.48M |
| Minority interest | - | 10.57M | 0.35M | - | - |
| Net income | 0.37M | 148.76M | 115.05M | -990.73M | -990.73M |
| Selling general administrative | - | 2086.15M | 1798.41M | 1805.49M | 1822.79M |
| Selling and marketing expenses | - | 155.36M | 162.03M | - | - |
| Gross profit | 3.90M | 2246.28M | 1568.87M | 1415.41M | 1415.41M |
| Reconciled depreciation | - | 290.04M | 252.59M | 184.06M | 126.24M |
| Ebit | 0.41M | 97.46M | 57.49M | -379.53M | -379.53M |
| Ebitda | 0.51M | 387.50M | 310.08M | -228.07M | -228.07M |
| Depreciation and amortization | 0.10M | 290.04M | 252.59M | 151.46M | 151.46M |
| Operating income | 0.41M | -18.10M | -391.58M | -379.53M | -379.53M |
| Other operating expenses | 3.63M | 8317.24M | 7219.52M | 5789.35M | 5789.35M |
| Interest expense | 0.39M | 49.74M | 36.87M | 11.95M | 11.95M |
| Tax provision | - | -90.48M | -94.43M | 30.81M | 576.25M |
| Interest income | - | 0.01M | 1.11M | 6.07M | 0.84M |
| Net interest income | - | -49.74M | -35.76M | -3.73M | -11.11M |
| Income tax expense | 0.01M | -90.48M | -94.43M | 576.25M | 576.25M |
| Total revenue | 4.04M | 8299.13M | 6827.94M | 5409.82M | 5409.82M |
| Total operating expenses | 3.49M | 2264.39M | 1960.45M | 1794.94M | 1794.94M |
| Cost of revenue | 0.14M | 6052.85M | 5259.07M | 3994.41M | 3994.41M |
| Total other income expense net | -0.03M | 65.81M | 412.20M | -34.95M | -34.95M |
| Net income from continuing ops | - | 138.19M | 115.05M | 148.97M | -990.73M |
| Net income applicable to common shares | - | - | - | - | -990.73M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 4156.76M | 8090.67M | 6849.19M | 5753.06M | 5753.06M |
| Intangible assets | - | 1139.30M | 920.70M | 391.04M | 391.04M |
| Other current assets | 22.56M | 217.17M | 515.86M | 111.17M | 111.17M |
| Total liab | 2821.89M | 6902.61M | 6633.23M | 5961.40M | 5961.40M |
| Total stockholder equity | 1334.87M | 933.27M | 210.88M | -208.34M | -208.34M |
| Other current liab | 42.64M | 740.25M | 1632.12M | 1943.92M | 1943.92M |
| Common stock | 20.01M | 352.62M | 20.00M | 1223.23M | 1223.23M |
| Capital stock | - | 352.62M | 20.00M | 1223.23M | 1223.23M |
| Retained earnings | 594.16M | 229.04M | 80.28M | -2694.03M | -2694.03M |
| Other liab | - | - | - | - | 889.61M |
| Good will | 16.15M | 389.13M | 484.56M | 600.33M | 600.33M |
| Other assets | 0.00M | - | - | - | 1077.28M |
| Cash | 20.14M | 329.40M | 106.35M | 370.62M | 370.62M |
| Total current liabilities | 2041.77M | 4181.48M | 3560.59M | 3196.47M | 3196.47M |
| Current deferred revenue | 37.40M | 463.19M | 512.05M | 104.18M | 104.18M |
| Net debt | 2313.58M | 3627.57M | 3542.92M | 2422.18M | 2422.18M |
| Short term debt | 1737.56M | 1905.26M | 1263.84M | 917.47M | 917.47M |
| Short long term debt | - | 1112.48M | 500.42M | 99.17M | 162.25M |
| Short long term debt total | 2333.72M | 3956.97M | 3649.27M | 2792.80M | 2792.80M |
| Other stockholder equity | 716.86M | 351.61M | 110.60M | 1262.46M | 1262.46M |
| Property plant equipment | - | - | - | - | 2249.09M |
| Total current assets | 3570.98M | 2706.06M | 1758.70M | 1382.30M | 1382.30M |
| Long term investments | - | 87.42M | 81.54M | 53.02M | 53.02M |
| Net tangible assets | - | - | - | - | -1199.71M |
| Short term investments | - | 6.16M | 0.50M | 26.53M | 26.53M |
| Net receivables | 3528.29M | 2001.70M | 1227.94M | 855.29M | 855.29M |
| Long term debt | - | 764.20M | 1050.80M | 1149.77M | 746.59M |
| Inventory | - | 151.64M | 139.98M | 18.70M | 18.70M |
| Accounts payable | 224.17M | 1014.21M | 137.70M | 230.90M | 230.90M |
| Accumulated other comprehensive income | 3.83M | - | 0.00M | - | - |
| Non currrent assets other | 178.87M | 973.46M | 961.14M | 107.22M | 107.22M |
| Non current assets total | 585.78M | 5384.61M | 5090.48M | 4370.76M | 4370.76M |
| Capital lease obligations | - | 2080.29M | 2098.05M | 1982.40M | 1883.96M |
| Breakdown | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Investments | 361.39M | -328.58M | 580.44M | -72.92M | 36.30M |
| Change to liabilities | - | - | - | -104.36M | -216.17M |
| Total cashflows from investing activities | 361.39M | -328.58M | - | -83.94M | -139.60M |
| Net borrowings | 324.96M | 300.92M | - | -253.97M | -253.97M |
| Total cash from financing activities | 1193.34M | 461.21M | -427.95M | -427.95M | 1432.13M |
| Change to operating activities | - | - | - | 147.97M | 80.42M |
| Net income | 138.19M | 115.05M | -990.73M | -990.73M | -539.17M |
| Change in cash | 223.05M | -499.11M | -1069.12M | -1069.12M | 926.11M |
| Begin period cash flow | 106.35M | 605.45M | 1439.73M | 1439.73M | 513.62M |
| End period cash flow | 329.40M | 106.35M | 370.62M | 370.62M | 1439.73M |
| Total cash from operating activities | -1331.68M | -631.74M | -557.23M | -557.23M | -366.42M |
| Issuance of capital stock | 868.38M | 0.00M | 0.00M | 0.00M | 1168.63M |
| Depreciation | 290.04M | 252.59M | 126.24M | 126.24M | 62.29M |
| Other cashflows from investing activities | -478.18M | -774.41M | - | 48.07M | 23.30M |
| Change to inventory | -10.61M | -25.87M | -2.44M | -2.44M | -2.44M |
| Change to account receivables | 299.96M | 580.68M | -37.02M | -37.02M | 189.14M |
| Other cashflows from financing activities | 260.28M | 160.29M | -176.87M | -176.87M | 649.94M |
| Change to netincome | - | - | - | 306.01M | 34.15M |
| Capital expenditures | 564.81M | 135.84M | 113.78M | 113.78M | 104.12M |
| Change in working capital | 1.97M | 498.76M | 1.25M | 1.25M | 76.31M |
| Stock based compensation | - | 0.00M | 196.85M | 196.85M | 139.51M |
| Other non cash items | -1573.17M | -1396.50M | -442.33M | -442.33M | 1.90M |
| Free cash flow | -1896.49M | -767.58M | -671.01M | -671.01M | -470.55M |
Sector: Consumer Cyclical Industry: Personal Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| MRM Medirom Healthcare Technologies Inc |
0.02 6.01% |
0.28 | 2.07 | - | 0.00 | 4.13 | 0.61 | 14.25 |
| ROL Rollins Inc |
-0.36 0.95% |
38.05 | 32.16 | 27.78 | 4.14 | 11.88 | 4.59 | 20.86 |
| SCI Service Corporation International |
1.04 1.40% |
75.40 | 21.26 | 17.61 | 2.53 | 7.21 | 3.69 | 12.18 |
| ANDG Andersen Group Inc. |
-0.13 0.20% |
65.64 | 126.07 | - | 6.71 | - | 7.24 | - |
| HRB H&R Block Inc |
- -% |
50.99 | 8.06 | 7.26 | 1.43 | 47.99 | 1.72 | 6.42 |
MEDIROM Healthcare Technologies Inc., together with its subsidiaries, provides holistic health services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment develops, owns, operates, franchises, and supports relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. This segment operates relaxation salons under the Re.Ra.Ku and Ruam Ruam brands. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program that utilizes Lav, an on-demand health monitoring smartphone application, as well as MOTHER Bracelet for fitness and health applications; and provides preventative healthcare services utilizing nutritionists and health nurses. The Luxury Beauty segment manages and operates hair salons under the ZACC brand name. The company also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
| Name | Title | Year Born |
|---|---|---|
| Mr. Kouji Eguchi | CEO & Representative Director | 1974 |
| Mr. Fumitoshi Fujiwara | CFO & Director | 1966 |
| Mr. Akira Aoki | Exec. Officer & Chief Medical Officer | NA |
| Mr. Akira Aoki | Executive Officer & Chief Medical Officer | NA |
| Mr. Fumitoshi Fujiwara | CFO & Director | 1967 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.